From what 4 stock analysts predict, the share price for Shockwave Medical Inc (SWAV) might decrease by 7.68% in the next year. This is based on a 12-month average estimation for SWAV. Price targets go from $165.00 to $275.00. The majority of stock analysts believe SWAV is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
Shockwave Medical Inc has a total of 4 Wall St Analyst ratings. There are 2 buy ratings, 1 ratings, and 1 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Shockwave Medical Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
adam maeder Piper Sandler | Buy | $275.0 | reiterated | Jan 12, 2024 |
larry biegelsen Wells Fargo | Hold | $200.0 | maintained | Jan 12, 2024 |
mike kratky Leerink Partners | Buy | None | maintained | Jan 10, 2024 |
suraj kalia Oppenheimer | Sell | $165.0 | maintained | Dec 21, 2023 |
patrick wood Morgan Stanley | Buy | $223.0 | maintained | Dec 4, 2023 |
william plovanic Canaccord Genuity | Buy | $236.0 | maintained | Nov 7, 2023 |
imron zafar Deutsche Bank | Buy | $270.0 | maintained | Nov 7, 2023 |
michael matson Needham | Buy | $260.0 | maintained | Nov 7, 2023 |
travis steed Bank of America Securities | Buy | $250.0 | reiterated | Nov 6, 2023 |
danielle antalffy UBS | Hold | $226.0 | maintained | Oct 24, 2023 |
michael polark Wolfe Research | Buy | $270.0 | maintained | Aug 8, 2023 |
cecilia furlong Morgan Stanley | Hold | $291.0 | maintained | May 9, 2023 |
bob hopkins Bank of America Securities | Hold | $200.0 | downgraded | Jul 12, 2021 |
In 2023, SWAV generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that SWAV's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SPLK-USD
$154.42
TEAM-USD
$216.17
TXN-USD
$162.4
UPST-USD
$33.9
TXG-USD
$49.11
TWKS-USD
$4.41